Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Perner

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Pyridopyrimidine analogues as novel adenosine kinase inhibitorsG Z Zheng, C Lee, J K Pratt, et al.
Pain|March 16, 2011
Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulationJun Chen, Shailen K Joshi, Stanley DiDomenico, et al.
Journal of Medicinal Chemistry|February 4, 2005
Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moietiesArthur Gomtsyan, Erol K Bayburt, Robert G Schmidt, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonistsIrene Drizin, Arthur Gomtsyan, Erol K Bayburt, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacyEric A Voight, Arthur R Gomtsyan, Jerome F Daanen, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Pyridopyrimidine analogues as novel adenosine kinase inhibitorsG Z Zheng, C Lee, J K Pratt, et al.
Pain|March 16, 2011
Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulationJun Chen, Shailen K Joshi, Stanley DiDomenico, et al.
Journal of Medicinal Chemistry|February 4, 2005
Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moietiesArthur Gomtsyan, Erol K Bayburt, Robert G Schmidt, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonistsIrene Drizin, Arthur Gomtsyan, Erol K Bayburt, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacyEric A Voight, Arthur R Gomtsyan, Jerome F Daanen, et al.
Pageof 4